These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32329219)

  • 1. A simplified method for the efficient purification and refolding of recombinant human TRAIL.
    Zhang Z; Hahn SB; Cao TM; King MR
    Biotechnol Prog; 2020 Sep; 36(5):e3007. PubMed ID: 32329219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient refolding of the bifunctional therapeutic fusion protein VAS-TRAIL by a triple agent solution.
    Fan J; Wang Z; Huang L; Shen Y
    Protein Expr Purif; 2016 Sep; 125():68-73. PubMed ID: 26358405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity.
    Fan J; Huang L; Sun J; Qiu Y; Zhou J; Shen Y
    J Biotechnol; 2015 Sep; 209():16-22. PubMed ID: 26072465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization Studies on Prokaryotic Cell Expression of the Human Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
    Hao L; Zhang ZG; Shi ZD; Pang K; Zhang JJ; Dong Y; Han CH
    Cell Biochem Biophys; 2015 Nov; 73(2):275-279. PubMed ID: 25737132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and refolding of a novel trimeric fusion protein TRAIL-collagen XVIII NC1.
    Pan LQ; Xie ZM; Tang XJ; Wu M; Wang FR; Naranmandura H; Chen SQ
    Appl Microbiol Biotechnol; 2013 Aug; 97(16):7253-64. PubMed ID: 23208613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Wang D; Shi L
    Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
    Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
    Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target cell-restricted apoptosis induction by 528scFv-TRAIL fusion protein specific for human EGFR and expressed in Escherichia coli.
    Badran A; Asano R; Nakayama M; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kumagai I
    Int J Oncol; 2010 May; 36(5):1229-34. PubMed ID: 20372797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
    Kang H; Sun AY; Shen YL; Wei DZ
    Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
    Shen YL; Xia XX; Zhang Y; Liu JW; Wei DZ; Yang SL
    Biotechnol Lett; 2003 Dec; 25(24):2097-101. PubMed ID: 14969416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
    Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
    Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fused hydrophobic elastin-like-peptides (ELP) enhance biological activity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Huang K; Duan N; Zou W; Zhang C; Lai Y; Shen P; Hua Z
    Protein Pept Lett; 2015; 22(11):1000-6. PubMed ID: 26299999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.
    Li P; Gu Q; Wu X
    Protein Expr Purif; 2016 Oct; 126():115-121. PubMed ID: 27335160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity.
    Yan J; Wang L; Wang Z; Wang Z; Wang B; Zhu R; Bi J; Wu J; Zhang H; Wu H; Yu B; Kong W; Yu X
    Cell Death Dis; 2016 Jun; 7(6):e2274. PubMed ID: 27336718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification and characterization of heterotrimeric forms of sTRAIL using a polycistronic expression vector.
    Wang B; Wang Z; Yan J; Wang L; Wang Z; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    Protein Expr Purif; 2015 Nov; 115():118-24. PubMed ID: 26256060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and purification of recombinant Trail protein in E.coli and the optimal conditions for Trail purification].
    Cai YY; Li XY; Wu Y; DU JC; Xu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):596-600. PubMed ID: 22691351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, refolding and purification of Ov-GRN-1, a granulin-like growth factor from the carcinogenic liver fluke, that causes proliferation of mammalian host cells.
    Smout MJ; Mulvenna JP; Jones MK; Loukas A
    Protein Expr Purif; 2011 Oct; 79(2):263-70. PubMed ID: 21757010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli.
    Wang Z; Zhang M; Lv X; Fan J; Zhang J; Sun J; Shen Y
    Sci Rep; 2018 Oct; 8(1):15766. PubMed ID: 30361617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.
    Reis CR; van der Sloot AM; Szegezdi E; Natoni A; Tur V; Cool RH; Samali A; Serrano L; Quax WJ
    Biochemistry; 2009 Mar; 48(10):2180-91. PubMed ID: 19236007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.